TY - JOUR T1 - The role of hypermethylation of the<em>hMLH1</em> promoter region in HNPCC versus MSI+ sporadic colorectal cancers JF - Journal of Medical Genetics JO - J Med Genet SP - 588 LP - 592 DO - 10.1136/jmg.37.8.588 VL - 37 IS - 8 AU - J M D Wheeler AU - A Loukola AU - L A Aaltonen AU - N J McC Mortensen AU - W F Bodmer Y1 - 2000/08/01 UR - http://jmg.bmj.com/content/37/8/588.abstract N2 - INTRODUCTION Hypermethylation of the promoter region of the hMLH1 gene is associated with absent expression of MLH1 protein in sporadic colorectal cancers with microsatellite instability (MSI+), and it has been proposed that methylation may be a mechanism of inactivation in Knudson's hypothesis. The incidence of hypermethylation of thehMLH1 promoter in hereditary non-polyposis colorectal cancer (HNPCC) versus MSI+ sporadic colorectal cancer was investigated and compared. METHODS DNA was available from 10 HNPCC colorectal cancers (median age 58 years, range 39-67) with germline mutations in hMLH1 and 10 MSI+ sporadic colorectal cancers (mean age 79 years, range 41-85). MSI was determined by amplification of BAT26 and TGF-β RII. The methylation status of the hMLH1 promoter was studied by the polymerase chain reaction (PCR) basedHpaII restriction enzyme assay technique. Evidence of allelic loss at hMLH1 was searched for in the HNPCC colorectal cancers. RESULTS All cases were confirmed to be MSI+. The promoter region of hMLH1 was hypermethylated in seven of 10 MSI+ sporadic cancers versus 0 of 10 HNPCC cancers (p&lt;0.002). Evidence of loss of heterozygosity athMLH1 was observed in eight of the 10 HNPCC colorectal cancers. CONCLUSION While mutations and allelic loss are responsible for the MSI+ phenotype in HNPCC cancers, the majority of MSI+ sporadic cancers are hypermethylated in the promoter region of hMLH1. These data further support our argument that tumours from HNPCC patients, which almost always acquire a raised mutation rate, mostly follow a different pathway from MSI+ sporadic tumours. ER -